6,473 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Bought by Chung Wu Investment Group LLC

Chung Wu Investment Group LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, Holdings Channel reports. The firm bought 6,473 shares of the healthcare conglomerate’s stock, valued at approximately $3,274,000. UnitedHealth Group accounts for 3.3% of Chung Wu Investment Group LLC’s investment portfolio, making the stock its 9th biggest holding.

A number of other large investors have also added to or reduced their stakes in UNH. Hudson Value Partners LLC grew its position in shares of UnitedHealth Group by 8.3% in the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after purchasing an additional 82 shares in the last quarter. Wealth Group Ltd. lifted its holdings in shares of UnitedHealth Group by 4.0% in the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock worth $1,039,000 after buying an additional 68 shares in the last quarter. Howard Capital Management Group LLC purchased a new position in UnitedHealth Group during the third quarter valued at approximately $341,000. GSG Advisors LLC lifted its stake in UnitedHealth Group by 14.4% in the 3rd quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate’s stock worth $435,000 after purchasing an additional 94 shares in the last quarter. Finally, Cary Street Partners Asset Management LLC increased its holdings in shares of UnitedHealth Group by 4.7% in the third quarter. Cary Street Partners Asset Management LLC now owns 803 shares of the healthcare conglomerate’s stock worth $470,000 after purchasing an additional 36 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Trading Up 0.3 %

NYSE UNH opened at $476.22 on Thursday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company’s 50-day simple moving average is $514.58 and its two-hundred day simple moving average is $554.81. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market capitalization of $438.25 billion, a price-to-earnings ratio of 30.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the business posted $5.83 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on UNH shares. Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Barclays dropped their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Finally, Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.